nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—FPGS—retina—malignant glioma	0.0262	0.0819	CbGeAlD
Pralatrexate—SLC19A1—central nervous system—malignant glioma	0.0206	0.0642	CbGeAlD
Pralatrexate—SLC19A1—cerebellum—malignant glioma	0.0201	0.0628	CbGeAlD
Pralatrexate—DHFR—embryo—malignant glioma	0.0193	0.0601	CbGeAlD
Pralatrexate—FPGS—medulla oblongata—malignant glioma	0.019	0.0592	CbGeAlD
Pralatrexate—DHFR—retina—malignant glioma	0.017	0.0532	CbGeAlD
Pralatrexate—FPGS—spinal cord—malignant glioma	0.0169	0.0528	CbGeAlD
Pralatrexate—SLC19A1—brain—malignant glioma	0.0164	0.051	CbGeAlD
Pralatrexate—TYMS—telencephalon—malignant glioma	0.0158	0.0494	CbGeAlD
Pralatrexate—DHFR—telencephalon—malignant glioma	0.0157	0.0489	CbGeAlD
Pralatrexate—FPGS—central nervous system—malignant glioma	0.0137	0.0428	CbGeAlD
Pralatrexate—FPGS—cerebellum—malignant glioma	0.0134	0.0418	CbGeAlD
Pralatrexate—DHFR—medulla oblongata—malignant glioma	0.0123	0.0384	CbGeAlD
Pralatrexate—TYMS—midbrain—malignant glioma	0.0114	0.0355	CbGeAlD
Pralatrexate—DHFR—midbrain—malignant glioma	0.0113	0.0351	CbGeAlD
Pralatrexate—DHFR—spinal cord—malignant glioma	0.011	0.0343	CbGeAlD
Pralatrexate—FPGS—brain—malignant glioma	0.0109	0.034	CbGeAlD
Pralatrexate—TYMS—central nervous system—malignant glioma	0.009	0.0281	CbGeAlD
Pralatrexate—DHFR—central nervous system—malignant glioma	0.00891	0.0278	CbGeAlD
Pralatrexate—TYMS—cerebellum—malignant glioma	0.0088	0.0274	CbGeAlD
Pralatrexate—DHFR—cerebellum—malignant glioma	0.00871	0.0272	CbGeAlD
Pralatrexate—TYMS—brain—malignant glioma	0.00715	0.0223	CbGeAlD
Pralatrexate—DHFR—brain—malignant glioma	0.00708	0.0221	CbGeAlD
Pralatrexate—Sepsis—Carmustine—malignant glioma	0.00556	0.0458	CcSEcCtD
Pralatrexate—Liver function test abnormal—Carmustine—malignant glioma	0.0043	0.0353	CcSEcCtD
Pralatrexate—Hypokalaemia—Carmustine—malignant glioma	0.00423	0.0348	CcSEcCtD
Pralatrexate—Dehydration—Temozolomide—malignant glioma	0.00418	0.0344	CcSEcCtD
Pralatrexate—Hypokalaemia—Temozolomide—malignant glioma	0.00409	0.0337	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00405	0.0333	CcSEcCtD
Pralatrexate—Pancytopenia—Carmustine—malignant glioma	0.00382	0.0314	CcSEcCtD
Pralatrexate—Neutropenia—Carmustine—malignant glioma	0.00376	0.0309	CcSEcCtD
Pralatrexate—Pancytopenia—Temozolomide—malignant glioma	0.00369	0.0304	CcSEcCtD
Pralatrexate—Neutropenia—Temozolomide—malignant glioma	0.00363	0.0299	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00361	0.0297	CcSEcCtD
Pralatrexate—Back pain—Carmustine—malignant glioma	0.00271	0.0223	CcSEcCtD
Pralatrexate—Back pain—Temozolomide—malignant glioma	0.00262	0.0215	CcSEcCtD
Pralatrexate—Anaemia—Carmustine—malignant glioma	0.00259	0.0213	CcSEcCtD
Pralatrexate—Leukopenia—Carmustine—malignant glioma	0.00251	0.0206	CcSEcCtD
Pralatrexate—Anaemia—Temozolomide—malignant glioma	0.0025	0.0206	CcSEcCtD
Pralatrexate—Leukopenia—Temozolomide—malignant glioma	0.00242	0.0199	CcSEcCtD
Pralatrexate—Cough—Temozolomide—malignant glioma	0.00236	0.0194	CcSEcCtD
Pralatrexate—Oedema—Carmustine—malignant glioma	0.00229	0.0188	CcSEcCtD
Pralatrexate—Thrombocytopenia—Carmustine—malignant glioma	0.00224	0.0184	CcSEcCtD
Pralatrexate—Tachycardia—Carmustine—malignant glioma	0.00223	0.0184	CcSEcCtD
Pralatrexate—Oedema—Temozolomide—malignant glioma	0.00221	0.0182	CcSEcCtD
Pralatrexate—Anorexia—Carmustine—malignant glioma	0.00218	0.0179	CcSEcCtD
Pralatrexate—Thrombocytopenia—Temozolomide—malignant glioma	0.00216	0.0178	CcSEcCtD
Pralatrexate—Anorexia—Temozolomide—malignant glioma	0.00211	0.0173	CcSEcCtD
Pralatrexate—Dyspnoea—Carmustine—malignant glioma	0.00204	0.0168	CcSEcCtD
Pralatrexate—Decreased appetite—Carmustine—malignant glioma	0.00199	0.0164	CcSEcCtD
Pralatrexate—Dyspnoea—Temozolomide—malignant glioma	0.00197	0.0162	CcSEcCtD
Pralatrexate—Constipation—Carmustine—malignant glioma	0.00196	0.0161	CcSEcCtD
Pralatrexate—Decreased appetite—Temozolomide—malignant glioma	0.00192	0.0158	CcSEcCtD
Pralatrexate—Fatigue—Temozolomide—malignant glioma	0.00191	0.0157	CcSEcCtD
Pralatrexate—Constipation—Temozolomide—malignant glioma	0.00189	0.0155	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Carmustine—malignant glioma	0.00187	0.0154	CcSEcCtD
Pralatrexate—Abdominal pain—Carmustine—malignant glioma	0.00181	0.0149	CcSEcCtD
Pralatrexate—Body temperature increased—Carmustine—malignant glioma	0.00181	0.0149	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00181	0.0149	CcSEcCtD
Pralatrexate—Abdominal pain—Temozolomide—malignant glioma	0.00175	0.0144	CcSEcCtD
Pralatrexate—Body temperature increased—Temozolomide—malignant glioma	0.00175	0.0144	CcSEcCtD
Pralatrexate—Asthenia—Carmustine—malignant glioma	0.00164	0.0135	CcSEcCtD
Pralatrexate—Asthenia—Temozolomide—malignant glioma	0.00159	0.013	CcSEcCtD
Pralatrexate—Diarrhoea—Carmustine—malignant glioma	0.00156	0.0129	CcSEcCtD
Pralatrexate—Pruritus—Temozolomide—malignant glioma	0.00156	0.0129	CcSEcCtD
Pralatrexate—Diarrhoea—Temozolomide—malignant glioma	0.00151	0.0124	CcSEcCtD
Pralatrexate—Vomiting—Carmustine—malignant glioma	0.00145	0.012	CcSEcCtD
Pralatrexate—Rash—Carmustine—malignant glioma	0.00144	0.0119	CcSEcCtD
Pralatrexate—Dermatitis—Carmustine—malignant glioma	0.00144	0.0118	CcSEcCtD
Pralatrexate—Vomiting—Temozolomide—malignant glioma	0.00141	0.0116	CcSEcCtD
Pralatrexate—Rash—Temozolomide—malignant glioma	0.00139	0.0115	CcSEcCtD
Pralatrexate—Dermatitis—Temozolomide—malignant glioma	0.00139	0.0115	CcSEcCtD
Pralatrexate—Nausea—Carmustine—malignant glioma	0.00136	0.0112	CcSEcCtD
Pralatrexate—Nausea—Temozolomide—malignant glioma	0.00131	0.0108	CcSEcCtD
Pralatrexate—TYMS—Cell Cycle—HIST1H3B—malignant glioma	0.00122	0.00219	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.00122	0.00219	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—SLC5A5—malignant glioma	0.00121	0.00218	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.00121	0.00217	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTT1—malignant glioma	0.0012	0.00215	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.00119	0.00214	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—COX8A—malignant glioma	0.00118	0.00211	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.00117	0.00209	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00115	0.00206	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.00115	0.00206	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN2B—malignant glioma	0.00113	0.00203	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BCAN—malignant glioma	0.00113	0.00202	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS1—malignant glioma	0.00112	0.00201	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00111	0.00199	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.0011	0.00197	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—MYC—malignant glioma	0.0011	0.00197	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TOP2A—malignant glioma	0.00109	0.00196	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—H3F3A—malignant glioma	0.00108	0.00194	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.00108	0.00194	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HES1—malignant glioma	0.00108	0.00193	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NCOR1—malignant glioma	0.00107	0.00192	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.00107	0.00191	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.00106	0.00189	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—BCHE—malignant glioma	0.00104	0.00187	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—YWHAE—malignant glioma	0.00104	0.00187	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—SLC5A5—malignant glioma	0.00103	0.00185	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—PPARG—malignant glioma	0.00103	0.00185	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—COX8A—malignant glioma	0.00103	0.00184	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PDGFRA—malignant glioma	0.00103	0.00184	CbGpPWpGaD
Pralatrexate—DHFR—Disease—DTX1—malignant glioma	0.00102	0.00182	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.00102	0.00182	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ASMT—malignant glioma	0.001	0.0018	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GSTP1—malignant glioma	0.000978	0.00175	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN2B—malignant glioma	0.000962	0.00172	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—MYC—malignant glioma	0.000958	0.00172	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TOP2A—malignant glioma	0.000953	0.00171	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CAT—malignant glioma	0.000951	0.00171	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TERT—malignant glioma	0.000945	0.00169	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HLA-A—malignant glioma	0.000945	0.00169	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—H3F3A—malignant glioma	0.000944	0.00169	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—BCAN—malignant glioma	0.000943	0.00169	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000942	0.00169	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000936	0.00168	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000925	0.00166	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PDGFB—malignant glioma	0.000923	0.00165	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—FGFR1—malignant glioma	0.000918	0.00165	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HES1—malignant glioma	0.000917	0.00164	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NCOR1—malignant glioma	0.000912	0.00164	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—YWHAE—malignant glioma	0.00091	0.00163	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HIF1A—malignant glioma	0.000904	0.00162	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—NCOR1—malignant glioma	0.000898	0.00161	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000889	0.00159	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000876	0.00157	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000876	0.00157	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ASMT—malignant glioma	0.000875	0.00157	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CAV1—malignant glioma	0.000874	0.00157	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PDGFRA—malignant glioma	0.000873	0.00157	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000872	0.00156	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000863	0.00155	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000844	0.00151	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTP1—malignant glioma	0.000831	0.00149	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—BCAN—malignant glioma	0.000823	0.00147	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—BAD—malignant glioma	0.000822	0.00147	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOTCH1—malignant glioma	0.000814	0.00146	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CAT—malignant glioma	0.000809	0.00145	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000807	0.00145	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HLA-A—malignant glioma	0.000804	0.00144	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TERT—malignant glioma	0.000804	0.00144	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HEY2—malignant glioma	0.000799	0.00143	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD80—malignant glioma	0.000798	0.00143	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—APC—malignant glioma	0.000797	0.00143	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—BRCA2—malignant glioma	0.00079	0.00142	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGF—malignant glioma	0.000787	0.00141	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PDGFB—malignant glioma	0.000785	0.00141	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000783	0.0014	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2B—malignant glioma	0.000783	0.0014	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTPN11—malignant glioma	0.000783	0.0014	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FGFR1—malignant glioma	0.000781	0.0014	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IDH1—malignant glioma	0.00078	0.0014	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HIF1A—malignant glioma	0.000769	0.00138	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000764	0.00137	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—NCOR1—malignant glioma	0.000764	0.00137	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—IDH2—malignant glioma	0.00076	0.00136	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000756	0.00135	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—BRAF—malignant glioma	0.000749	0.00134	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CAV1—malignant glioma	0.000744	0.00133	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HEY1—malignant glioma	0.00074	0.00133	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000736	0.00132	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CAV1—malignant glioma	0.000732	0.00131	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT2—malignant glioma	0.000729	0.00131	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HIST1H3B—malignant glioma	0.000719	0.00129	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2B6—malignant glioma	0.000714	0.00128	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—PTEN—malignant glioma	0.000707	0.00127	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CD—malignant glioma	0.0007	0.00126	CbGpPWpGaD
Pralatrexate—FPGS—Disease—BAD—malignant glioma	0.000699	0.00125	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOTCH1—malignant glioma	0.000693	0.00124	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—BRCA2—malignant glioma	0.000689	0.00124	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2B—malignant glioma	0.000683	0.00122	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD80—malignant glioma	0.000678	0.00122	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APC—malignant glioma	0.000677	0.00121	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—BIRC5—malignant glioma	0.000676	0.00121	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—FGF2—malignant glioma	0.00067	0.0012	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGF—malignant glioma	0.000669	0.0012	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CG—malignant glioma	0.000667	0.0012	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTPN11—malignant glioma	0.000665	0.00119	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000665	0.00119	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—IDH2—malignant glioma	0.000663	0.00119	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000659	0.00118	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JAG2—malignant glioma	0.000656	0.00118	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TERT—malignant glioma	0.000655	0.00117	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—IDH1—malignant glioma	0.000653	0.00117	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PPARG—malignant glioma	0.000644	0.00115	CbGpPWpGaD
Pralatrexate—FPGS—Disease—BRAF—malignant glioma	0.000637	0.00114	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SPHK1—malignant glioma	0.000632	0.00113	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MDM2—malignant glioma	0.000627	0.00112	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—RAF1—malignant glioma	0.000625	0.00112	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2B6—malignant glioma	0.000623	0.00112	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CAV1—malignant glioma	0.000623	0.00112	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT2—malignant glioma	0.00062	0.00111	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2C18—malignant glioma	0.000619	0.00111	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ERBB2—malignant glioma	0.000618	0.00111	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000612	0.0011	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CB—malignant glioma	0.00061	0.00109	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—malignant glioma	0.000605	0.00108	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000598	0.00107	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CD—malignant glioma	0.000595	0.00107	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—BIRC5—malignant glioma	0.00059	0.00106	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CD—malignant glioma	0.000586	0.00105	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TERT—malignant glioma	0.000571	0.00102	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—IDH1—malignant glioma	0.00057	0.00102	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FGF2—malignant glioma	0.00057	0.00102	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00057	0.00102	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CG—malignant glioma	0.000567	0.00102	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000565	0.00101	CbGpPWpGaD
Pralatrexate—DHFR—Disease—H3F3A—malignant glioma	0.000555	0.000995	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SPHK1—malignant glioma	0.000552	0.000989	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PPARG—malignant glioma	0.000547	0.000981	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2C18—malignant glioma	0.00054	0.000969	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MDM2—malignant glioma	0.000533	0.000956	CbGpPWpGaD
Pralatrexate—FPGS—Disease—RAF1—malignant glioma	0.000532	0.000953	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTEN—malignant glioma	0.000527	0.000946	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ERBB2—malignant glioma	0.000526	0.000943	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JAG1—malignant glioma	0.000523	0.000938	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000519	0.000931	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CB—malignant glioma	0.000519	0.00093	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—malignant glioma	0.000514	0.000922	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FBXW7—malignant glioma	0.000513	0.000919	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CB—malignant glioma	0.000511	0.000916	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—malignant glioma	0.000506	0.000908	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000502	0.000901	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTT1—malignant glioma	0.000501	0.000898	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000501	0.000898	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CD—malignant glioma	0.000499	0.000894	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—malignant glioma	0.000482	0.000865	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—STAT3—malignant glioma	0.000472	0.000846	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS1—malignant glioma	0.000469	0.000842	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTEN—malignant glioma	0.000448	0.000804	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—malignant glioma	0.000448	0.000803	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTEN—malignant glioma	0.000442	0.000792	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MYC—malignant glioma	0.000438	0.000786	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTT1—malignant glioma	0.000437	0.000784	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000437	0.000783	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—BCHE—malignant glioma	0.000436	0.000782	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CB—malignant glioma	0.000435	0.000779	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MDM2—malignant glioma	0.000434	0.000779	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC5A5—malignant glioma	0.000431	0.000773	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—malignant glioma	0.000431	0.000772	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—malignant glioma	0.000429	0.000769	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000424	0.000761	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS1—malignant glioma	0.00041	0.000734	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—KRAS—malignant glioma	0.000405	0.000726	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN2B—malignant glioma	0.000402	0.00072	CbGpPWpGaD
Pralatrexate—FPGS—Disease—STAT3—malignant glioma	0.000401	0.000719	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—malignant glioma	0.000391	0.000701	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HES1—malignant glioma	0.000383	0.000687	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NCOR1—malignant glioma	0.000381	0.000683	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—BCHE—malignant glioma	0.000381	0.000683	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MDM2—malignant glioma	0.000379	0.000679	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC5A5—malignant glioma	0.000376	0.000674	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTEN—malignant glioma	0.000376	0.000673	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MYC—malignant glioma	0.000373	0.000668	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CA—malignant glioma	0.000372	0.000667	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PDGFRA—malignant glioma	0.000365	0.000654	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—malignant glioma	0.000364	0.000653	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTP1—malignant glioma	0.000347	0.000623	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KRAS—malignant glioma	0.000344	0.000617	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYC—malignant glioma	0.000339	0.000608	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CAT—malignant glioma	0.000338	0.000606	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TERT—malignant glioma	0.000336	0.000602	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HLA-A—malignant glioma	0.000336	0.000602	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PDGFB—malignant glioma	0.000328	0.000588	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGFR1—malignant glioma	0.000326	0.000585	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HIF1A—malignant glioma	0.000321	0.000576	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NCOR1—malignant glioma	0.000319	0.000572	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CA—malignant glioma	0.000316	0.000567	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CA—malignant glioma	0.000312	0.000559	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CAV1—malignant glioma	0.000311	0.000557	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT1—malignant glioma	0.000304	0.000545	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYC—malignant glioma	0.000303	0.000544	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTP1—malignant glioma	0.000303	0.000543	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYC—malignant glioma	0.000296	0.000531	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CAT—malignant glioma	0.000295	0.000529	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BAD—malignant glioma	0.000292	0.000524	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOTCH1—malignant glioma	0.000289	0.000519	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD80—malignant glioma	0.000283	0.000508	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APC—malignant glioma	0.000283	0.000507	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGF—malignant glioma	0.00028	0.000501	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOR1—malignant glioma	0.000278	0.000499	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTPN11—malignant glioma	0.000278	0.000498	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BRAF—malignant glioma	0.000266	0.000477	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CA—malignant glioma	0.000265	0.000475	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYC—malignant glioma	0.000265	0.000475	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CAV1—malignant glioma	0.00026	0.000466	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT2—malignant glioma	0.000259	0.000464	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT1—malignant glioma	0.000258	0.000463	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKT1—malignant glioma	0.000255	0.000456	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—malignant glioma	0.000249	0.000447	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CD—malignant glioma	0.000249	0.000446	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF2—malignant glioma	0.000238	0.000427	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CG—malignant glioma	0.000237	0.000425	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPARG—malignant glioma	0.000229	0.00041	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CAV1—malignant glioma	0.000227	0.000407	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MDM2—malignant glioma	0.000223	0.000399	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RAF1—malignant glioma	0.000222	0.000398	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB2—malignant glioma	0.00022	0.000394	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—malignant glioma	0.000217	0.00039	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CB—malignant glioma	0.000217	0.000389	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKT1—malignant glioma	0.000216	0.000388	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—malignant glioma	0.000215	0.000385	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CD—malignant glioma	0.000208	0.000373	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CG—malignant glioma	0.000207	0.000371	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPARG—malignant glioma	0.0002	0.000358	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTEN—malignant glioma	0.000187	0.000336	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CD—malignant glioma	0.000182	0.000326	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CB—malignant glioma	0.000182	0.000325	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—malignant glioma	0.00018	0.000323	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT3—malignant glioma	0.000168	0.0003	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CB—malignant glioma	0.000158	0.000284	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—malignant glioma	0.000157	0.000281	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTEN—malignant glioma	0.000157	0.000281	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MYC—malignant glioma	0.000156	0.000279	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—malignant glioma	0.000152	0.000273	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KRAS—malignant glioma	0.000144	0.000258	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTEN—malignant glioma	0.000137	0.000245	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CA—malignant glioma	0.000132	0.000237	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CA—malignant glioma	0.000111	0.000198	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT1—malignant glioma	0.000108	0.000194	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CA—malignant glioma	9.66e-05	0.000173	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKT1—malignant glioma	9.04e-05	0.000162	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKT1—malignant glioma	7.89e-05	0.000141	CbGpPWpGaD
